Emily Shelby, MSN, FNP-C, emphasized that referrals to other specialties is key to managing heavily pretreated patients with metastatic colorectal cancer.
Regorafenib, Fruquintinib, and TAS-102: mCRC Treatment After Chemotherapy
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML
2
Progression Occurs Early in R/R LBCL Treated With Epcoritamab, Glofitamab
3
Frontline Axi-Cel CR Linked With Improved Survival in High-Risk LBCL
4
Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer
5
